How did the Medibank (ASX:MPL) share price perform in 2021?

The company's shares performed reasonably well last year.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price had a modest run over the past 12 months. The company managed to navigate itself through tough market conditions caused by COVID-19.

In 2021, Medibank shares gained 11%, which was almost in line with the broader S&P/ASX 200 Index (ASX: XJO). The latter rose around 13.5% across the same timeframe.

At yesterday's market close, the private health insurance company's shares closed 0.3% higher to $3.40 apiece. A sharp contrast compared to the benchmark index which fell heavily by 2.74% to 7,358.3 points.

What happened to the Medibank share price in 2021?

The Medibank share price rose strongly during the first half of the year, underpinned by solid growth across key financial metrics.

Management noted that more people are continuing to prioritise their health and wellbeing through private health insurance. This is due to the uncertainty surrounding COVID-19 and heightened pressure on the public system.

Notably, the company experienced its biggest growth in more than 10 years, with market share up 37 basis points. 

In addition, ongoing focus on Medibank customers led to improved retention, and record customer advocacy levels.

Undoubtedly, this helped push the company's shares to near record highs during the months of August and September.

Fast-forward to November, Medibank shares slightly backtracked due to the rapid spread of the Omicron variant. Rules regarding density limits as well as ongoing restrictions in Victoria and New South Wales have impacted the health system.

The uncertainty of when the post-COVID era will actually happen has driven the company's shares momentarily lower.

Is this a buying opportunity?

A couple of brokers weighed in on the Medibank share price during the final months of 2021.

Multinational investment bank, Macquarie raised its 12-month price target by 2.9% to $3.55 for Medibank shares. This implies an upside of around 4.4% based on the current share price.

Following suit, Australian investment firm, Morgans also lifted its assessment on Medibank shares by 8.2% to also $3.55. Its analysts believe that there is still some value left in the private health insurance company.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Financial Shares

A man with long hair and tattoos holds out an EFTPOS payment machine from behind a shop counter.
Financial Shares

1 dirt-cheap ASX stock I'd buy as Aussie cash carrier looks for a lifeline

Every crisis comes with an opportunity. I reckon this payments company is in the buy zone as cash crumbles.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Financial Shares

Why is this ASX 300 stock crashing 23% today?

Shareholders of this stock have been hit with some bad news.

Read more »

Happy man working on his laptop.
Financial Shares

3 things about AFIC stock every smart investor knows

These are underrated factors about the LIC.

Read more »

Frazzled couple sitting out their kitchen table trying to figure out their finances or taxes.
Dividend Investing

Here's the AMP dividend forecast through to 2026

There is some good news for AMP shareholders.

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Soul Patts share price struggles on falling profits

ASX 200 investment house Soul Patts reported its half year results this morning.

Read more »

Financial Shares

Buy this ASX All Ords stock for a 15% gain and 9% dividend yield

Goldman Sachs is tipping big returns from this stock.

Read more »

Man pointing at a blue rising share price graph.
Financial Shares

Big ASX news: Macquarie share price hits new 52-week high

It's been a great day to own Macquarie shares...

Read more »

a woman wearing a dark business suit holds her hand up in a stop gesture while sitting at a desk. She has a sombre look on her face.
Financial Shares

Guess which ASX All Ords stock is suspended amid takeover rumours

Another ASX share is rumoured to have received a takeover offer.

Read more »